RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q2 2026 · 240 positions · Total reported value $2.05B · Top-10 concentration 24.1% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 240 equity positions with a combined reported value of $2.05B. The filing implies a diversified portfolio: its ten largest positions account for 24.1% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q2 2026 were LGND ($85.36M), ACIW ($50.62M), ARLO ($50.32M). By sector, the heaviest allocations are Health Care 31.6%, Consumer Discretionary 25.0%. Versus the prior quarter, allocation shifted toward Health Care (+3.0pp), Real Estate (+2.1pp) and away from Utilities (-0.7pp), Consumer Discretionary (-1.8pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 89% of names.

The largest new positions opened in Q2 2026 were OSK ($16.27M), PAR ($6.60M), SHLS ($6.44M).

Of the 12 positions fully exited versus the prior quarter, the largest were FOLD ($11.14M), SLNO ($6.90M), AMPH ($3.67M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • OSK OSHKOSH CORP · $16.27M
  • PAR PAR TECHNOLOGY CORP · $6.60M
  • SHLS SHOALS TECHNOLOGIES GROUP IN · $6.44M
  • ATEC ALPHATEC HLDGS INC · $5.69M
  • CECO CECO ENVIRONMENTAL CORP · $3.51M
  • BMI BADGER METER INC · $3.01M
  • PJT PJT PARTNERS INC · $2.75M
  • COST COSTCO WHOLESALE CORPORATION · $935.47K

Fully Exited (vs previous quarter)

  • FOLD AMICUS THERAPEUTIC · prev qtr: $11.14M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $6.90M
  • AMPH AMPHASTAR PHARMACEUTICALS IN · prev qtr: $3.67M
  • VITL VITAL FARMS INC · prev qtr: $3.14M
  • THR THERMON GROUP HLDGS INC · prev qtr: $2.88M
  • ADMA ADMA BIOLOGICS INC · prev qtr: $2.71M
  • GO GROCERY OUTLET HLDG CORP · prev qtr: $2.31M
  • LZ LEGALZOOM COM INC · prev qtr: $2.00M

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 31.6%
Technology 20.0%
Financials 4.0%
Utilities 2.5%
Other 3.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 270.05K $85.36M 4.15%
4.15%
Reduce
2 1.01M $50.62M 2.46%
2.46%
Hold
3 3.73M $50.32M 2.45%
2.45%
Add
4 87.58K $49.23M 2.40%
2.40%
Reduce
5 560.93K $48.13M 2.34%
2.34%
Add
6 224.88K $46.17M 2.25%
2.25%
Hold
7 821.50K $43.02M 2.09%
2.09%
Add
8 874.49K $42.54M 2.07%
2.07%
Add
9 624.93K $39.96M 1.95%
1.95%
Add
10 148.64K $39.65M 1.93%
1.93%
Hold
11 438.98K $37.86M 1.84%
1.84%
Hold
12 689.69K $32.60M 1.59%
1.59%
Add
13 775.12K $32.52M 1.58%
1.58%
Reduce
14 475.50K $29.01M 1.41%
1.41%
Reduce
15 54.12K $28.66M 1.40%
1.40%
Hold
16 177.15K $28.42M 1.38%
1.38%
Hold
17 330.47K $28.05M 1.36%
1.36%
Add
18 629.87K $27.10M 1.32%
1.32%
Add
19 485.01K $27.03M 1.32%
1.32%
Reduce
20 351.20K $26.22M 1.28%
1.28%
Add
21 178.61K $25.20M 1.23%
1.23%
Reduce
22 1.60M $23.92M 1.16%
1.16%
Add
23 608.48K $23.80M 1.16%
1.16%
Add
24 118.09K $23.53M 1.15%
1.15%
Add
25 2.33M $23.32M 1.14%
1.14%
Add
26 2.78M $23.21M 1.13%
1.13%
Add
27 834.00K $22.93M 1.12%
1.12%
Add
28 490.22K $22.80M 1.11%
1.11%
Add
29 1.18M $21.60M 1.05%
1.05%
Add
30 680.85K $21.01M 1.02%
1.02%
Hold
31 390.87K $20.48M 1.00%
1.00%
Hold
32 2.19M $19.75M 0.96%
0.96%
Add
33 570.26K $19.15M 0.93%
0.93%
Add
34 1.06M $18.63M 0.91%
0.91%
Add
35 189.91K $18.22M 0.89%
0.89%
Add
36 247.69K $18.13M 0.88%
0.88%
Add
37 678.26K $17.86M 0.87%
0.87%
Reduce
38 382.62K $17.36M 0.84%
0.84%
Add
39 100.19K $16.89M 0.82%
0.82%
Hold
40 387.55K $16.46M 0.80%
0.80%
Add
41 106.01K $16.27M 0.79%
0.79%
New
42 117.08K $15.94M 0.78%
0.78%
Hold
43 618.89K $15.66M 0.76%
0.76%
Hold
44 142.66K $15.11M 0.73%
0.73%
Add
45 1.45M $15.08M 0.73%
0.73%
Add
46 278.91K $14.99M 0.73%
0.73%
Add
47 248.22K $14.20M 0.69%
0.69%
Add
48 1.99M $13.57M 0.66%
0.66%
Add
49 259.43K $13.51M 0.66%
0.66%
Hold
50 110.67K $12.96M 0.63%
0.63%
Reduce

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 240 equity positions worth $2.05B in aggregate; its largest disclosed positions were LGND ($85.36M), ACIW ($50.62M), ARLO ($50.32M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $2.05B of long equity holdings across 240 positions as of 2026-Q2. Top-10 holdings account for 24.1% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →